About AllCells

Founded in 1998, AllCells, a Discovery Life Sciences company, is a market-leading provider of highly characterized primary cell and tissue products, supporting global biomedical organizations seeking to develop and manufacture novel drugs and cell therapies. By providing Clinical Grade and RUO products, custom donor management services, and integrated analytical capabilities, AllCells' comprehensive solutions streamline every stage of development to help bring novel therapies to market faster. Our FDA-registered, IRB-approved, AABB-compliant donor facilities strategically located across the U.S. provide access to healthy, recallable, well-characterized donors with diverse and rare demographics. Our adjacently located processing facilities enable immediate processing, cryopreservation, and a high degree of responsiveness to accommodate custom requests with exceptional quality and deliverability. Backed by over 30 years of combined scientific and regulatory expertise, AllCells is committed to providing flexible and scalable solutions necessary to dynamic, client-specific needs and timelines from inception to commercialization. AllCells – Science at your Service™

website icon
Website
employees icon
Employees
industry icon
Industry
Biotechnology
location icon
Location
1301 Harbor Bay Parkway, Suite 200, Alameda, CA 94502, US
description icon
Founded
1998
description icon
Keywords
Stem Cells, Bone Marrow, Cord Blood, Human Primary Cells, Gmp Allogeneic Clinical Grade Primary Cells, Leukopak, Mobilized Leukopak, Pbmcs, Cd34+ Stem Cells

AllCells Alternatives

Frequently Asked Questions about AllCells

Who are the decision makers in AllCells?

The decision makers in AllCells are Angela Martinovic, Annie Liu, Conor Marino, etc. Click to Find AllCells decision makers emails.

Supercharge your
Prospecting &
Outreach with
ContactOut

Search Portal

Find countless prospects outside of LinkedIn fast

Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.

Discover the source of our data

Learn more